• Version
• Download 7
• File Size 440.89 MB
• File Count 1
• Create Date March 11, 2026
• Last Updated March 11, 2026

Largest Real - World Data of a MCED test in ASIA

Key insights from real-world MCED implementation | The International Hereditary Cancers Congress 2026

Dr. Nguyen Luu Hong Dang delivered an Oral Presentation at the International Hereditary Cancers Congress, held on February 5–8, 2026, in Antalya, Turkey.

The presentation is based on Abstract (AbsRef: 0111) entitled: “Real-World Evidence for a Multi-Cancer Early Detection Test Based on Multimodal Analysis of Cell-Free DNA Across Asia.”

Key highlights of the Oral presentation include:

- Large-scale real-world data from over 36,000 asymptomatic participants (12,281 completed 12-month follow-up compliance)

- Assessment of SPOT-MAS performance in routine clinical practice, beyond controlled clinical trial settings

- Improved positive predictive value (PPV) in a real-world population, supporting clinical applicability

- Detection of both precancerous lesions and invasive cancers, including cancer types without established standard-of-care screening

- Insights into the role of MCED as a complementary cancer screening tool in real-world healthcare settings